Department of Health Policy and Management, Korea University, Seoul, South Korea.
Interdisciplinary Program in Precision Public Health, Department of Public Health Sciences, Korea University, Seoul, South Korea.
Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):933-943. doi: 10.1158/1055-9965.EPI-23-1567.
According to the stem cell hypothesis, breast carcinogenesis may be related to the breast stem cell pool size. However, little is known about associations of breast cancer risk factors, such as anthropometric measures, with the expression of stem cell markers in noncancerous breast tissue.
The analysis included 414 women with biopsy-confirmed benign breast disease in the Nurses' Health Study and Nurses' Health Study II. Birthweight, weight at age 18, current weight, and current height were reported via self-administered questionnaires. IHC staining of stem cell markers (CD44, CD24, and aldehyde dehydrogenase family 1 member A1) in histopathologically normal epithelial and stromal breast tissue was quantified using an automated computational image analysis system. Linear regression was used to examine the associations of early-life and adult anthropometric measures with log-transformed stem cell marker expression, adjusting for potential confounders.
Birthweight [≥10.0 vs. <5.5 lbs: β (95% confidence interval) = 4.29 (1.02, 7.56); P trend = 0.001 in the stroma] and adult height [≥67.0 vs. <63.0 inch: 0.86 (0.14, 1.58); P trend = 0.02 in the epithelium and stroma combined] were positively associated with CD44 expression. Childhood body fatness was inversely associated (P trend = 0.03) whereas adult height was positively associated with CD24 expression in combined stroma and epithelium (P trend = 0.03).
Our data suggest that anthropometric measures, such as birthweight, adult height, and childhood body fatness, may be associated with the stem cell expression among women with benign breast disease.
Anthropometric measures, such as birthweight, height, and childhood body fatness, may have long-term impacts on stem cell population in the breast.
根据干细胞假说,乳腺癌的发生可能与乳腺干细胞池的大小有关。然而,关于乳腺癌风险因素(如人体测量指标)与非癌性乳腺组织中干细胞标志物表达的关联,人们知之甚少。
该分析纳入了护士健康研究和护士健康研究 II 中 414 名经活检证实患有良性乳腺疾病的女性。通过自我管理问卷报告出生体重、18 岁时的体重、当前体重和当前身高。使用自动计算图像分析系统对组织病理学正常的上皮和基质乳腺组织中的干细胞标志物(CD44、CD24 和醛脱氢酶家族 1 成员 A1)进行免疫组化染色,并对其进行量化。采用线性回归来检验早期和成年人体测量指标与对数转换的干细胞标志物表达之间的关联,同时调整潜在混杂因素。
出生体重[≥10.0 磅 vs. <5.5 磅:β(95%置信区间)= 4.29(1.02,7.56);趋势 P 值=0.001 于基质中]和成年身高[≥67.0 英寸 vs. <63.0 英寸:0.86(0.14,1.58);趋势 P 值=0.02 于上皮和基质联合中]与 CD44 表达呈正相关。儿童时期体脂含量呈负相关(趋势 P 值=0.03),而成年身高与联合基质和上皮中的 CD24 表达呈正相关(趋势 P 值=0.03)。
我们的数据表明,人体测量指标,如出生体重、成年身高和儿童体脂含量,可能与患有良性乳腺疾病的女性的干细胞表达有关。
人体测量指标,如出生体重、身高和儿童体脂含量,可能对乳腺中的干细胞群体产生长期影响。